Sio CF - Search Results

1

Quorum quenching by an N-acyl-homoserine lactone acylase from Pseudomonas aeruginosa PAO1.

Sio CF, Otten LG, Cool RH, Diggle SP, Braun PG, Bos R, Daykin M, Cámara M, Williams P, Quax WJ. Sio CF, et al. Infect Immun. 2006 Mar;74(3):1673-82. doi: 10.1128/IAI.74.3.1673-1682.2006. Infect Immun. 2006. PMID: 16495538 Free PMC article.

2

Mutational analysis of a key residue in the substrate specificity of a cephalosporin acylase.

Otten LG, Sio CF, van der Sloot AM, Cool RH, Quax WJ. Otten LG, et al. Among authors: sio cf. Chembiochem. 2004 Jun 7;5(6):820-5. doi: 10.1002/cbic.200300764. Chembiochem. 2004. PMID: 15174165

3

Altering the substrate specificity of cephalosporin acylase by directed evolution of the Beta -subunit.

Otten LG, Sio CF, Vrielink J, Cool RH, Quax WJ. Otten LG, et al. Among authors: sio cf. J Biol Chem. 2002 Nov 1;277(44):42121-7. doi: 10.1074/jbc.M208317200. Epub 2002 Aug 26. J Biol Chem. 2002. PMID: 12198140 Free article.

4

Directed evolution of a glutaryl acylase into an adipyl acylase.

Sio CF, Riemens AM, van der Laan JM, Verhaert RM, Quax WJ. Sio CF, et al. Eur J Biochem. 2002 Sep;269(18):4495-504. doi: 10.1046/j.1432-1033.2002.03143.x. Eur J Biochem. 2002. PMID: 12230561 Free article.

5

Analysis of a substrate specificity switch residue of cephalosporin acylase.

Sio CF, Otten LG, Cool RH, Quax WJ. Sio CF, et al. Biochem Biophys Res Commun. 2003 Dec 19;312(3):755-60. doi: 10.1016/j.bbrc.2003.10.180. Biochem Biophys Res Commun. 2003. PMID: 14680829

6

Improved beta-lactam acylases and their use as industrial biocatalysts.

Sio CF, Quax WJ. Sio CF, et al. Curr Opin Biotechnol. 2004 Aug;15(4):349-55. doi: 10.1016/j.copbio.2004.06.006. Curr Opin Biotechnol. 2004. PMID: 15358003 Review.

7

A highly active adipyl-cephalosporin acylase obtained via rational randomization.

Otten LG, Sio CF, Reis CR, Koch G, Cool RH, Quax WJ. Otten LG, et al. Among authors: sio cf. FEBS J. 2007 Nov;274(21):5600-10. doi: 10.1111/j.1742-4658.2007.06081.x. Epub 2007 Oct 8. FEBS J. 2007. PMID: 17922842 Free article.

8

PET-CT imaging with [(18)F]-gefitinib to measure Abcb1a/1b (P-gp) and Abcg2 (Bcrp1) mediated drug-drug interactions at the murine blood-brain barrier.

Vlaming ML, Läppchen T, Jansen HT, Kivits S, van Driel A, van de Steeg E, van der Hoorn JW, Sio CF, Steinbach OC, DeGroot J. Vlaming ML, et al. Among authors: sio cf. Nucl Med Biol. 2015 Nov;42(11):833-41. doi: 10.1016/j.nucmedbio.2015.07.004. Epub 2015 Jul 15. Nucl Med Biol. 2015. PMID: 26264927

9

Validation of interventional fiber optic spectroscopy with MR spectroscopy, MAS-NMR spectroscopy, high-performance thin-layer chromatography, and histopathology for accurate hepatic fat quantification.

Nachabé R, van der Hoorn JW, van de Molengraaf R, Lamerichs R, Pikkemaat J, Sio CF, Hendriks BH, Sterenborg HJ. Nachabé R, et al. Among authors: sio cf. Invest Radiol. 2012 Apr;47(4):209-16. doi: 10.1097/RLI.0b013e318237527b. Invest Radiol. 2012. PMID: 22233757

10

Automated synthesis of [18F]gefitinib on a modular system.

Läppchen T, Vlaming ML, Custers E, Lub J, Sio CF, DeGroot J, Steinbach OC. Läppchen T, et al. Among authors: sio cf. Appl Radiat Isot. 2012 Jan;70(1):205-9. doi: 10.1016/j.apradiso.2011.09.005. Epub 2011 Sep 17. Appl Radiat Isot. 2012. PMID: 21975107

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page